Skip to content

Now On-Demand: The future of health and pharmacy policy in the second Trump administration

The Inauguration Day program that was featured as a session at the NACDS Regional Chain Conference and as a webinar for NACDS members and allies now is available for viewing online.

Photo by René DeAnda / Unsplash

Table of Contents

BONITA SPRINGS, Fla. — As you consider what the second term of President Trump means for health and pharmacy policy, the following likely come to mind:

  • RFK, Jr., Dr. Oz, and Other Trump Nominees to Health Agencies
  • Vaccine Policy in the New Administration
  • PBM Reform
  • DOGE, Regulatory Reform and the End of the 40-Year “Chevron Deference”
  • Food is Medicine in the New Administration
  • Tariffs, Economic Growth and Inflation
  • The 2024 Elections: “Mandates and Margins” in the 119th Congress
  • Who’s on Deck for President in 2028
  • And Much More.

The Inauguration Day program that was featured today as a session at the NACDS Regional Chain Conference and as a webinar for NACDS members and allies now is available for viewing online.

Participants include:

  • Steve Anderson, President and CEO, National Association of Chain Drug Stores
  • Keith Nahigian, President, Nahigian Strategies
  • Jack Kalavritinos, Founder and Principal, JK Strategies.

They have more than eight decades of combined policy and political knowledge and expertise from holding senior positions in Presidential and Congressional election campaigns, serving in senior staff positions in Congress, serving in the White House, and leading federal health agencies in Washington, D.C.

 Please share this program with your teams, colleagues, association members, collaborators, pharmacists and employees, and student pharmacists

Comments

Latest